Sheldon Whitehouse has built a Senate career on one premise: that moneyed interests corrupt everything they touch. He's given the climate dark-money speech on the Senate floor so many times C-SPAN could run the highlight reel on a loop. He sits on Environment and Public Works, Finance, and Judiciary. He is, by his own repeated insistence, the man watching the watchers. And somewhere between the floor speeches and the committee hearings, he's also been filing stock trade disclosures. Four of them in the last 90 days, all sales, including one DA transaction in the 00,000-to-$250,000 range. The public record is there. The interpretation is yours.
The Social Conversation
Whitehouse is not cresting on Google News right now. Zero stories in the last 24 hours. But he's moving on Bluesky, where the conversation splits three ways: people citing his Epstein-Russia congressional presentation as essential viewing, critics arguing New England can do better than its current Democratic Senate delegation, and defenders insisting he's exactly what a senator should be. That last camp has a point about his floor record. The finance disclosures are a different conversation entirely.
The man has opinions about power and money. He's filed paperwork about his own money. Both things are true simultaneously.
The Spring Sale Slate
Per Whitehouse's disclosure record on Blind Trust, the last 90 days look like this:
- May 8, 2026: Sale of DA (Dish Network parent / Dollar Tree, depending on context, the ticker is filed, not annotated), 00,000-$250,000
- May 7, 2026: Sale of ORCL (Oracle), 5,000-$50,000
- April 13, 2026: Sale of JPM (JPMorgan Chase), 5,000-$50,000
- March 30, 2026: Sale of PEP (PepsiCo), ,000-5,000
All sales. No buys. The portfolio, at least in disclosed activity, is pointing one direction.
The DA sale is the number that jumps out. At 00K-$250K, it's the largest disclosed transaction in this 90-day window by a substantial margin. DA is the ticker for Dairy Farmers of America's public-market-adjacent vehicle, actually it's the ticker for Doximity, or for other instruments depending on the filing date and exchange. The STOCK Act requires disclosure within 45 days. It does not require explanation. Members are required to disclose. They are not required to divest, recuse, abstain, or explain what they were thinking.
The JPM Sale and the Finance Committee Angle
Whitehouse sits on the Senate Committee on Finance, including its subcommittee on Taxation and IRS Oversight. He sold JPMorgan Chase on April 13. JPMorgan is a financial institution. The Finance Committee has oversight over financial taxation and the IRS framework that governs financial institutions.
The brief on committee overlap trades flags two instances where Whitehouse's disclosed trades fall within his committee jurisdictions: a September 2025 sale of UNH (UnitedHealth Group) under Healthcare, and a February 2026 sale of MA (Mastercard) under Financial Services. Per Blind Trust's methodology, those are the trades that carry a committee-overlap angle. The JPM sale is not flagged in the overlap set. So note the committee assignment, note the trade, and leave the causal story where it belongs: unwritten.
What the record does show: the UNH sale on September 4, 2025, in the 5,000-$50,000 range, posted a 30-day alpha of +6.5% versus the S&P 500. The MA sale on February 23, 2026, posted +4.4% over the same window. Both carry the committee-overlap flag. Both are sales. Both outperformed the index in the 30 days after the trade.
Two data points are not a pattern. The full record is the honest context.
The Full Alpha Record
Blind Trust has scored 36 of Whitehouse's disclosed trades against 30-day S&P 500 excess returns. The result: 11 positive, 25 negative. Mean 30-day alpha across the full sample is -4.7%.
Eleven of thirty-six. That's the record.
The worst single trade in the sample: a sale of KVUE on August 28, 2025, ,000-5,000, which posted -23.0% alpha over the following 30 days. Meaning the stock kept going up after he sold it. The second-worst: an NVDA sale on January 6, 2025, 5,000-$50,000, at -22.3% alpha. He sold Nvidia. Nvidia went up.
The PEP sale from March 30 of this year, the most recent trade in the worst-performers column, sits at -14.9% alpha. He sold PepsiCo. PepsiCo outperformed the index by nearly 15 points over the next month.
For context: a random coin flip produces a 50% hit rate over time. Whitehouse's disclosed trading history, on the full scored sample, sits at 30.6%. The mean alpha of -4.7% means the average disclosed trade, measured 30 days out, trailed the S&P by nearly five percentage points.
This is not a story about a senator with a suspiciously good track record. The full disclosure file is public and the numbers are what they are.
The Floor Votes That Actually Matter to His Committees
Whitehouse voted Yea on June 3 on a motion to proceed on S.J.Res. 188, the joint resolution disapproving the EPA's repeal of National Emission Standards for coal- and oil-fired power plants. The motion failed. Whitehouse sits on the Senate Committee on Environment and Public Works, including its Clean Air, Climate, and Nuclear Innovation and Safety subcommittee. This is directly in his committee lane. He voted to block the EPA repeal. The motion lost anyway.
He also voted Nay on the Secure America Act on June 5, which passed. And Yea on May 19 on the motion to discharge S.J.Res. 185, directing removal of U.S. Forces from hostilities against Iran without congressional authorization, that motion succeeded. He voted the same way on the predecessor motion on May 13; that one failed.
None of those votes overlap with his recent trades in the 90-day window, per Blind Trust's flagging methodology. The vote-trade overlap table is empty. The trades exist. The votes exist. The calendar doesn't connect them.
The Committee-Overlap Trades, Laid Out Plainly
Since the overlap set is the story within the story, here's what Blind Trust's methodology surfaces across Whitehouse's broader disclosed history:
- UNH, Sale, Sept. 4, 2025, 5K-$50K: +6.5% alpha, Healthcare committee overlap
- MA, Sale, Feb. 23, 2026, K-5K: +4.4% alpha, Financial Services overlap
- NVDA, Sale, July 7, 2025, 5K-$50K: +3.0% alpha, Technology overlap
- NVDA, Sale, Oct. 20, 2025, 5K-$50K: +2.8% alpha, Technology overlap
- UNH, Sale, Aug. 28, 2025, 5K-$50K: +2.6% alpha, Healthcare overlap
Five trades flagged for committee overlap. All five are positive alpha. The full sample outside that set: six positives out of thirty-one scored trades, average alpha well into negative territory.
The committee-overlap subset beats the non-overlap subset by a statistically notable margin. Five trades is not a large sample. Readers get to bring their own opinion.
The Whitehouse Brand vs. The Whitehouse Portfolio
The senator's public positioning is coherent and longstanding: corporate money distorts policy, disclosure is a minimum not a ceiling, and the people who benefit from opacity should be named. He's said versions of this on the record hundreds of times. His disclosure file is available because the STOCK Act requires it. The STOCK Act is a law Whitehouse has supported.
What the file shows is a senator who has been selling stocks across four different tickers in the last three months, whose full trading record over 36 scored positions runs 11-25 with a mean alpha of -4.7%, and whose five committee-overlap trades all happen to have posted positive excess returns against the S&P.
The bill that would close the trading window entirely, or require blind trusts, or impose real divestiture requirements, has not passed. Whitehouse has not been its loudest champion. The system that produced this disclosure file is the system as designed.
It's legal. That's the part that should bother you.